Company intelligence / Profile preview
Virtici
Seattle, Washington, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Virtici establishes and incubates early therapeutic programs focused on immune-mediated, metabolic, infectious, and neurological diseases. Several pipeline candidates are at preclinical development stage, generating data and seeking or enabling further progression to clinical trial stage[1][2].
- Therapeutic areas
- NeurologyEndocrinologyOther
- Modalities
- Fusion proteinBispecific monoclonal antibodyRecombinant protein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Celdara MedicalCritical Path Institute (C-Path)NIH ASCEND Hub
Beyond the preview
Go deeper on Virtici.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virtici.